Dr. Lyle Craig Feinstein, MD

Dr. Feinstein practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Feinstein's NPI, 1871589416, was assigned on September 20, 2005. Dr. Feinstein graduated from University of Miami, Miller School of Medicine in 1996. Dr. Feinstein holds Florida license 84858.

Dr. Feinstein's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Feinstein's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Feinstein to 1 more breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feinstein practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Feinstein's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Feinstein is board certified in internal medicine by the American Board of Internal Medicine. Dr. Feinstein is licensed in Florida.

Dmand AI lists lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Feinstein treats.

CMS data shows 443 Medicare services from Dr. Feinstein across 1 procedure code in 2024, for 69 Medicare patients. Medicare paid $43,893 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Feinstein in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 3.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feinstein's median patient age at 71, with 48% women.

In 2024, Dr. Feinstein wrote 29 Medicare Part D claims for 21 patients. 72% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $156,454 in total drug cost. In 2016, CMS named 15 claims across 1 drug.

Dr. Feinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Feinstein in 2018. The most frequent topics are Transplantation, Homologous, Hematopoietic Stem Cell Transplantation and Immunosuppression Therapy. Dr. Feinstein has published most often in Biol Blood Marrow Transplant. Dr. Feinstein's most frequent co-authors are Michael Brian Maris, MD, Edward D. Agura, MD and Stephen J. Forman, MD.

CMS Open Payments shows 246 general payments to Dr. Feinstein from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $65,765.

Dmand AI lists 1 award for Dr. Feinstein, most recently CMS Stage 1 EHR in 2012.

Dr. Feinstein graduated from University of Miami, Miller School of Medicine in 1996.

Dr. Feinstein is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.